Status:
NOT_YET_RECRUITING
Outcome of Children With Eosinophilic Esophagitis
Lead Sponsor:
Fondation Lenval
Conditions:
Esophagitis, Eosinophilic
Eligibility:
All Genders
2-17 years
Phase:
NA
Brief Summary
The investigator would like to create a prospective cohort of patients in order to describe eosinophilic esophagitis with the specificities corresponding to our geographical territory, and to study th...
Detailed Description
The investigator would like to create a prospective cohort of 16 patients included over 2 years in order to determine the rate of complete remission (clinical, endoscopic and histological) at 3 months...
Eligibility Criteria
Inclusion
- Diagnosis of OE according to the diagnostic criteria of the PNDS published in July 2022
- Due to start treatment.
- informed consent from one of the 2 parents or the representative of parental authority.
- Membership of a social security scheme.
Exclusion
- \-
Key Trial Info
Start Date :
March 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2028
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT06190080
Start Date
March 1 2024
End Date
December 1 2028
Last Update
January 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpitaux pédiatriques de Nice CHU Lenval
Nice, France, 06200